Tax Season is Here! Save 15% on H&R Block Online
iconAll times are GMT -4. The time now is 06:22 PM. | Search:

» StockRants Stock Forum » Public Stock Forums » US Stock Picks » Buy: ACRS = MC$ 44 M /Cash $115 M / Phase 3 readout imminent



Reply
 
Thread Tools Search this Thread
Old 09-12-2019, 12:43 PM   Nav to Top  #1
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Default ACRS = MC$ 44 M /Cash $115 M / Phase 3 readout imminent

BRUTAL Hot Rebound Play which is massive underpriced here trading wayyy below cash

Market Cap $43 M / Cash $115 M or untill end 2021 / 2 Marketed Product / 1 Phase 3 trial (common warts) with results expected in Q4 2019 and many other phase 2 programs / because of their strategic change they wants to out-license all their Products which means HUGE upfront payments for the company (more infos below)= CHEAPEST Biotech you can get at this time

Aclaris Therapeutics (ACRS)

Market Cap: $43 M
Cash: $115 M or enough untill end 2021

Price $1.07


Aclaris Therapeutics Announces New Strategic Direction
https://investor.aclaristx.com/news-...egic-direction


ACRS aquired a attractive drug from Allergan last year paid $65 m upfront alone for this drug which they now looking to outlicense .
globenewswire.com
https://www.globenewswire.com/news-r...-Allergan.html


Pipeline
https://www.aclaristx.com/pipeline/


Largest Shareholders:

Deerfield Management Company LP...5 893 416
Franklin Advisers, Inc....3 953 203
BlackRock Fund Advisors ...2 359 223
Broadfin Capital LLC...2 280 260
D. E. Shaw & Co. LP....2 049 462
Sofinnova Ventures, Inc.....1 911 573
Vivo Capital LLC ....1 647 214
Fidelity Management & Research Co...1 562 190
Polar Capital LLP...1 443 920
The Vanguard Group, Inc...1 142 022
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 09-13-2019, 10:50 AM   Nav to Top  #2
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

the cheapest biotech you can get trading massive under cash who has 2 approved drugs and another phase 3 asset with results expected any day now ...


Morgan Stanley reports 5% passive stake in Aclaris Therapeutics...08/29,2019
https://thefly.com/landingPageNews.php?id=2956902


This new strategic direction includes the following actions:

Actively Seeking a Commercialization Partner for RHOFADE® (oxymetazoline hydrochloride) cream, 1%

Aclaris will also seek strategic partners for ESKATA® (hydrogen peroxide) topical solution, 40% (w/w)


Aclaris is actively seeking a strategic partner to commercialize its drug candidate A-101 45% Topical Solution, an investigational compound being developed as a potential treatment for verruca vulgaris (common warts). The Company’s two ongoing Phase 3 pivotal clinical trials, THWART-1 and THWART-2, in which A-101 45% Topical Solution is being evaluated as a potential treatment for common warts, are progressing as planned. Aclaris has completed enrollment of more than 1,000 patients across these two trials, and data from both trials are expected in the second half of 2019.

Aclaris is actively seeking a development and commercialization partner for its drug candidates, ATI-501 (oral) and ATI-502 (topical), which are investigational Janus Kinase (JAK) 1/3 inhibitor compounds for the potential treatment of alopecia.
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 09-16-2019, 03:05 PM   Nav to Top  #3
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Major breakout to $2+ could start anytime now

Biohero is offline   Rate this post Yes | No Reply With Quote
Old 09-16-2019, 05:03 PM   Nav to Top  #4
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

BOOOOOOOOOOOOOOOOOOOOOOOM and still trading below cash which alone is $2.80 per share


Aclaris Therapeutics’ A-101 45% Topical Solution Meets Primary and All Secondary Efficacy Endpoints in Pivotal Phase 3 Trial for the Treatment of Common Warts (THWART-2)
https://finance.yahoo.com/news/aclar...201540775.html
Biohero is offline   Rate this post Yes | No Reply With Quote
Old 09-17-2019, 06:30 AM   Nav to Top  #5
Biohero
Senior Trader
 
Biohero's Avatar
 
Join Date: Jan 2012
Location: Frankfurt
Posts: 239
Favorites: Aapl celg onxx
Rep Power: 104
Reputation: 36
Biohero is on a distinguished road
Thread Starter
Default

Exploding in pre mkt up 100% or $2.10 which is still below the $2.80 cash per share ..terrible underpriced
Biohero is offline   Rate this post Yes | No Reply With Quote
Reply

Similar Threads
Thread Thread Starter Forum Replies Last Post
Strong Buy: ARDX (MC $155 M) FDA Decision on Sept 12 & Phase 3 readout this Quarter Biohero US Stock Picks 2 09-03-2019 01:22 PM
Strong Buy: TNXP (MC $32M) (Cash $34M) O/S 7.5 M / Phase 3 Data in 1H 2018 =More than just cheap Biohero US Stock Picks 6 01-23-2018 04:48 AM
Strong Buy: AXSM (MC $83 M)(Cash $50 M) 4x BIG Phase 3 Ongoing =TOP PICK Biohero US Stock Picks 25 01-18-2018 09:22 AM
Strong Buy: ARDM (MC $49 M / Cash $40 M) Phase 3 Results for Real Blockbuster in 2H 2016 = 1000% Biohero US Stock Picks 1 04-17-2016 11:06 PM
Strong Buy: BLUSF (MC $17 M) (Cash $16M ) Big Rare Disease Drug in Phase 3 Close to End = 1000% Biohero US Penny Stock Picks 0 01-28-2014 09:20 AM


Thread Tools Search this Thread
Search this Thread:

Advanced Search

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is On